Visgeneer
Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cr… Read more
Visgeneer (4197) - Total Liabilities
Latest total liabilities as of June 2025: NT$147.58 Million TWD
Based on the latest financial reports, Visgeneer (4197) has total liabilities worth NT$147.58 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Visgeneer - Total Liabilities Trend (2011–2024)
This chart illustrates how Visgeneer's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Visgeneer Competitors by Total Liabilities
The table below lists competitors of Visgeneer ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First Andes Silver Ltd.
V:FAS
|
Canada | CA$522.49K |
|
Royalindo Investa Wijaya
JK:INDO
|
Indonesia | Rp5.90 Billion |
|
U10 SA
PA:ALU10
|
France | €73.79 Million |
|
Blockmate Ventures Inc.
OTCQB:MATEF
|
USA | $7.26 Million |
|
Nidaros Sparebank
OL:NISB
|
Norway | Nkr4.41 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Visgeneer's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Visgeneer's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Visgeneer (2011–2024)
The table below shows the annual total liabilities of Visgeneer from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$138.25 Million | -25.51% |
| 2023-12-31 | NT$185.60 Million | -27.38% |
| 2022-12-31 | NT$255.58 Million | +22.74% |
| 2021-12-31 | NT$208.23 Million | -14.65% |
| 2020-12-31 | NT$243.97 Million | -7.37% |
| 2019-12-31 | NT$263.37 Million | +30.32% |
| 2018-12-31 | NT$202.09 Million | -24.20% |
| 2017-12-31 | NT$266.61 Million | +28.32% |
| 2016-12-31 | NT$207.76 Million | -7.10% |
| 2015-12-31 | NT$223.64 Million | +218.59% |
| 2014-12-31 | NT$70.20 Million | +50.02% |
| 2013-12-31 | NT$46.79 Million | +45.00% |
| 2012-12-31 | NT$32.27 Million | +21.13% |
| 2011-12-31 | NT$26.64 Million | -- |